United States securities and exchange commission logo





                              January 13, 2022

       John Yozamp
       Chief Executive Officer
       Expion360 Inc.
       2025 SW Deerhound Avenue
       Redmond, OR 97756

                                                        Re: Expion360 Inc.
                                                            Draft Registration
Statement on Form S-1
                                                            Filed December 17,
2021
                                                            CIK No. 0001894954

       Dear Mr. Yozamp:

              We have reviewed your draft registration statement and have the
following comments. In
       some of our comments, we may ask you to provide us with information so
we may better
       understand your disclosure.

              Please respond to this letter by providing the requested
information and either submitting
       an amended draft registration statement or publicly filing your
registration statement on
       EDGAR. If you do not believe our comments apply to your facts and
circumstances or do not
       believe an amendment is appropriate, please tell us why in your
response.

             After reviewing the information you provide in response to these
comments and your
       amended draft registration statement or filed registration statement, we
may have additional
       comments.

       Draft Registration Statement on Form S-1

       Market Data, page ii

   1.                                                   We note the first
sentence of this section. In each instance throughout the prospectus
                                                        where you cite data,
please indicate the source of the data. In addition, please tell us
                                                        whether you
commissioned any of the third-party data included in your registration
                                                        statement, and if so
whether you are required to file any consents pursuant to Rule 436.
       Prospectus Summary, page 1

   2.                                                   Please provide
quantitative and qualitative support for the statement that you are an    an
                                                        industry leader    for
both lithium battery manufacturing and supporting accessories for
                                                        recreational vehicles
and your    success    in the industry. Also provide support for the
 John Yozamp
FirstName
Expion360 LastNameJohn Yozamp
           Inc.
Comapany
January 13,NameExpion360
            2022         Inc.
January
Page 2 13, 2022 Page 2
FirstName LastName
         assertion that you are    currently positioned to lead    the rapid
market conversion from
         lead-acid to lithium batteries as the primary method of power
sourcing. Finally, expand to
         explain how your true 12-year warranty is an industry    game-changer.

3.       Provide support for the assertions that your batteries have a lifespan
of 12 years three to
         four times that of lead-acid batteries and with ten times the number
of charging cycles,
         and that your typical battery provides three times the power than the
typical, lead-acid
         battery despite being half the weight.
4.       Please expand to discuss the nature of your partnerships with Camping
World, Electric
         World, Patrick Distribution, and NTP-STAG. Disclose whether you have
binding
         agreements with these entities, and if so discuss the terms of those
agreements and provide
         an analysis of whether you should file any agreements as exhibits.
Please also clarify the
         nature of your    planned partnerships    with Meyer Distributing and
Land    n Sea, and your
            plan to begin    partnerships with Lewis Marine Supply, Northern
Wholesale Supply, and
         Lorenz and Jones, such as whether you have binding agreements, LOIs,
MOUs or other
         arrangements with these entities.
Risk Factors, page 6

5.       You disclose on page 18 that you had total liabilities of $2,966,100
as of December 31,
         2020; however, per your balance sheet on page F-4, you had total
liabilities of $2,984,058
         as of December 31, 2020. Please revise your disclosure to address this
apparent
         discrepancy.
Use of Proceeds, page 20

6.       You disclose that you currently intend to use a portion of the net
proceeds for the
         repayment of indebtedness. Please tell us what consideration you gave
as to whether pro
         forma information, including pro forma earnings per share, should also
be provided
         related to the repayment of indebtedness. Refer to Rule 11-01(a)(8) of
Regulation S-X for
         further information.
Financial Information, page 25

7.       Please ensure that all amounts presented on page 27 agree to the
amounts presented on
         your audited statements of operations on page F-5. As currently
presented, there are
         several amounts on page 27 that do not agree to the corresponding
amounts on page F-5.
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Results of Operations, page 32

8.       Please review all percentage changes that you have disclosed
throughout MD&A, as it
         appears to us that the vast majority have not been presented
accurately. For example, you
         disclose on page 33 that sales for the nine months ended September 30,
2021 increased by
         278.3% compared to the nine months ended September 30, 2020. It
appears that sales for
 John Yozamp
FirstName
Expion360 LastNameJohn Yozamp
           Inc.
Comapany
January 13,NameExpion360
            2022         Inc.
January
Page 3 13, 2022 Page 3
FirstName LastName
         the nine months ended September 30, 2021 actually increased by 178.3%,
not 278.3%,
         compared to the nine months ended September 30, 2020.
9.       You disclose on page 35 that sales for the year ended December 31,
2020 increased
         compared to the year ended December 31, 2019. Based on the amounts
presented on your
         audited statements of operations on page F-5, sales for the year ended
December 31, 2020
         actually decreased compared to the year ended December 31, 2019.
Please revise your
         disclosure to address this apparent discrepancy.
Liquidity and Capital Resources, page 36

10.      Please enhance your disclosure on page 37 to also discuss the changes
in your operating,
         investing, and financing cash flows as depicted in your statements of
cash flows for the
         nine months ended September 30, 2021 and 2020 in accordance with the
SEC Interpretive
         Release No. 33-8350.
Competitive Strengths
Supply Chain, page 48

11.      We note the statement that    The following article provides more
insight into how lithium
         is used across various markets       Please provide the source of the
article and clarify
         which parts of your prospectus constitutes the article, and which
parts are your own
         disclosure. Please also clarify the two references to    [t]he
following link    as we could not
         find the links.
Executive Compensation, page 55

12.      Please update your compensation disclosure as of the fiscal year ended
December 31,
         2021. See Item 402 of Regulation S-K.
Transactions With Related Persons, Promoters and Certain Control Persons, page
61

13.      Please provide the disclosure required by Item 404(b) of Regulation
S-K.
Registration Rights, page 64

14.      Please disclose whether there are any maximum cash penalties under the
registration
         rights agreement, if applicable. Please also disclose any additional
penalties resulting
         from delays in registering your common stock. Refer to ASC
825-20-50-1.
Experts, page 74

15.      Given the fact that your financial statements as of and for the nine
months ended
         September 30, 2021 have actually not been included in reliance upon
the report of M&K
         CPAS PLLC, please revise your disclosure to only make reference to
your financial
         statements as of and for the years ended December 31, 2019 and 2020.
 John Yozamp
FirstName
Expion360 LastNameJohn Yozamp
           Inc.
Comapany
January 13,NameExpion360
            2022         Inc.
January
Page 4 13, 2022 Page 4
FirstName LastName
Balance Sheets, page F-4

16.      We note, per your audited balance sheet as of December 31, 2019, that
you had total
         current liabilities of $-204,154. Please confirm, if true, that you
actually had a contra
         current liability balance of $-204,154 as you indicate on page F-4;
otherwise, revise your
         presentation to state that you had total current liabilities of
$204,154 as of December 31,
         2019.
Statements of Operations, page F-5

17.      We note that your audited statements of operations for the years ended
December 31,
         2020 and 2019 do not sum to the correct amounts. As currently
presented, the amounts
         for gross profit, loss from operations, loss before taxes, franchise
taxes, net loss, and net
         loss per membership unit all appear to be inaccurately presented.
Please perform a
         comprehensive review and correct your audited statements of operations
as needed. In
         doing so, please ensure that you also correct all related disclosures
presented in MD&A
         and the footnotes to your financial statements, as applicable.
Statements of Cash Flows, page F-7

18.      You appear to have presented borrowings on your line of credit and
short-term revolving
         loans net of payments on pages F-7 and F-31. Please tell us how such a
presentation is
         consistent with ASC 230-10-45-7 through 9 or revise your presentation
accordingly.
Note 2. Summary of Significant Accounting Policies
Concentration of Major Customers, page F-12

19.      We note your disclosure that sales to four customers comprised
approximately 57% of
         total sales for the year ended December 31, 2020. We further note that
sales to two
         customers comprised approximately 30% of total sales for the year
ended December 31,
         2019. With reference to ASC 280-10-50-42, please disclose here and on
page F-37 the
         total amount of revenue from each customer who represented more than
ten percent of
         revenue for each period presented in the notes to your financial
statements.
Note 12. Commitments and Contingencies, page F-20

20.      You disclose on page F-21 that your total lease liability was $221,248
as of December 31,
         2020; however, you also disclose on page F-21 that your total lease
liability was $248,470
         as of December 31, 2020. Please revise your disclosure to address this
apparent
         discrepancy.
Note 15. Subsequent Events, page F-22

21.      We note that you revoked your election to be taxed as an S Corporation
and converted to a
         C Corporation effective November 16, 2021. As such, please tell us
what consideration
         you gave to SAB Topic 1:B.2.
 John Yozamp
Expion360 Inc.
January 13, 2022
Page 5
Recent Sales of Unregistered Securities, page Item15

22.      Indicate the section of the Securities Act or the rule of the
Commission under which
         exemption from registration was claimed and state briefly the facts
relied upon to make
         the exemption available. See Item 701(d) of Regulation S-K.
General

23.      We note that your forum selection provision in Article X of your
Articles of Incorporated
         filed as Exhibit 3.1 identifies the Nevada Eighth Judicial District
Court of Clark County
         Nevada as the exclusive forum for certain litigation, including any
"derivative action."
         Please disclose whether this provision applies to actions arising
under the Securities Act
         or Exchange Act. In that regard, we note that Section 27 of the
Exchange Act creates
         exclusive federal jurisdiction over all suits brought to enforce any
duty or liability created
         by the Exchange Act or the rules and regulations thereunder, and
Section 22 of the
         Securities Act creates concurrent jurisdiction for federal and state
courts over all suits
         brought to enforce any duty or liability created by the Securities Act
or the rules and
         regulations thereunder. If the provision applies to Securities Act
claims, please also revise
         your prospectus to state that there is uncertainty as to whether a
court would enforce such
         provision and that investors cannot waive compliance with the federal
securities laws and
         the rules and regulations thereunder. If this provision does not apply
to actions arising
         under the Securities Act or Exchange Act, please also ensure that the
exclusive forum
         provision in the governing documents states this clearly, or tell us
how you will inform
         investors in future filings that the provision does not apply to any
actions arising under the
         Securities Act or Exchange Act.
24.      In the Alternate Pages for the Resale Prospectus, please revise to
disclose a fixed price (or
         a range) at which the selling stockholders will sell their shares
until the securities are
         quoted on the Nasdaq, after which the securities can be offered and
sold at prevailing
         market prices or at negotiated prices.
       You may contact Jeff Gordon at 202-551-3866 or Kevin Stertzel at
202-551-3723 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Erin Donahue at 202-551-6001 or Anne Parker at 202-551-3611 with any
other
questions.



FirstName LastNameJohn Yozamp                                   Sincerely,
Comapany NameExpion360 Inc.
                                                                Division of
Corporation Finance
January 13, 2022 Page 5                                         Office of
Manufacturing
FirstName LastName